Hetal Bhakta
Clinical Cardiac Electrophysiology · Palm Springs, CANPI 1336248285
Payments from drug & device makers
Across 614 payments — averaging $166.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$37K
- Abbott$24K
- Cvrx, Inc.$19K
- Boston Scientific$19K
- Biosense Webster, Inc.$618
- Atricure, Inc.$603
- plus $2K from 24 others
What the payments were for
- Travel & lodging$3,07017%
- Food & beverage$14,80683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 269 | $36,666 |
| Abbott | 49 | $24,260 |
| Cvrx, Inc. | 3 | $19,356 |
| Boston Scientific | 197 | $18,543 |
| Biosense Webster, Inc. | 18 | $618 |
| Atricure, Inc. | 5 | $603 |
| Johnson & Johnson | 11 | $327 |
| Impulse Dynamics (USA) Inc. | 4 | $223 |
| E.r. Squibb & Sons, L.L.C. | 9 | $177 |
| Novartis | 9 | $174 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $170 |
| Biotronik Inc. | 2 | $145 |
| Lexicon Pharmaceuticals, Inc. | 1 | $116 |
| Bayer | 1 | $113 |
| Cardiva Medical, Inc. | 4 | $81 |
| ZOLL Respicardia, Inc. | 3 | $79 |
| Merck | 2 | $61 |
| Irhythm Technologies, Inc. | 2 | $60 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $57 |
| Medicomp Inc | 2 | $55 |
| Baxter Healthcare | 2 | $48 |
| Boehringer Ingelheim | 1 | $28 |
| Amgen | 1 | $27 |
| Imperative Care, Inc | 1 | $26 |
| Abiomed | 1 | $24 |
| Acutus Medical, Inc. | 1 | $23 |
| Stereotaxis Inc | 2 | $22 |
| Cordis US CORP. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$2,030
- Arctic Front$671
- LINQ II$552
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$399
- ATRICLIP LAA EXCLUSION SYSTEM$399
- Perclose ProGlide suture mediated closure system$393
- PERCLOSE PROGLIDE$378
- OPTIMIZER$257
- Confirm Rx$164
- Micra$161
- OCTARAY MAPPING CATHETER$150
- NUVISION ICE CATHETER$150
- Watchman$147
- AVEIR$139
- WATCHMAN Access System$135
- Proclaim Family of SCS IPGs$134
- Reveal LINQ$129
- XARELTO$125
- Solia$120
- BioMonitor$120
How this compares
$102,139 in reported general payments places this provider in the 70th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 553 | $615,951 |
| XareltoRivaroxaban | 123 | $155,289 |
| EntrestoSacubitril/Valsartan | 105 | $117,534 |
| JardianceEmpagliflozin | 24 | $20,537 |
| MultaqDronedarone Hcl | 18 | $19,328 |
| Repatha SureclickEvolocumab | 12 | $14,260 |
| BrilintaTicagrelor | 20 | $12,486 |
| Clonidine | 65 | $9,069 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 27 | $5,517 |
| Metoprolol Succinate | 277 | $4,177 |
| PradaxaDabigatran Etexilate Mesylate | 15 | $3,700 |
| Icosapent Ethyl | 15 | $3,437 |
| Carvedilol | 313 | $2,600 |
| Amlodipine Besylate | 338 | $2,231 |
| Amiodarone Hcl | 98 | $2,204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $615,951553 claims |
| Johnson & JohnsonXarelto | $327 | $155,289123 claims |
| NovartisEntresto | $174 | $117,534105 claims |
| Boehringer IngelheimJardiance, Pradaxa | $28 | $24,23739 claims |
| AstraZenecaBrilinta | $18 | $12,48620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Palm Springs
- David KrummenSan Diego$7.3M
- Jonathan DukesVentura$2.9M
- Shephal DoshiSanta Monica$2.9M
- Arash AryanaSacramento$2.4M
- Marco PerezStanford$2.1M
- Rahul DoshiLos Angeles$2M
- Mayer RashtianPasadena$1.8M
- Rajesh BankerNewport Beach$1.6M
- Edward GerstenfeldSan Francisco$1.5M
- Jonathan HsuSan Diego$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.